New drug approval [electronic resource] : FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints : report to the Ranking Member, Committee on Finance, U.S. Senate.
Imprint
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]